2019 | Kimberly D. Miller, MPH; Leticia Nogueira, PhD, MPH; Angela B. Mariotto, PhD; Julia H. Rowland, PhD; K. Robin Yabroff, PhD; Catherine M. Alfano, PhD; Ahmedin Jemal, DVM, PhD; Joan L. Kramer, MD; Rebecca L. Siegel, MPH
The report provides an overview of cancer survivorship in the United States, highlighting the increasing number of cancer survivors due to population growth and advancements in early detection and treatment. As of January 1, 2019, over 16.9 million Americans with a history of cancer were alive, a number projected to exceed 22.1 million by 2030. The most prevalent cancers in 2019 were prostate, colon and rectum, and melanoma among males, and breast, uterine corpus, and colon and rectum among females. More than half of survivors were diagnosed within the past decade, and nearly two-thirds are aged 65 or older. The report details treatment patterns, survival rates, and short-term and long-term health effects for various cancers, including breast, colorectal, leukemia, lymphoma, lung, melanoma, prostate, testicular, and thyroid cancers. It emphasizes the unique medical and psychosocial needs of cancer survivors and the importance of proactive assessment and management by follow-up care providers. The report also discusses the need for evidence-based resources to optimize care for this growing population.The report provides an overview of cancer survivorship in the United States, highlighting the increasing number of cancer survivors due to population growth and advancements in early detection and treatment. As of January 1, 2019, over 16.9 million Americans with a history of cancer were alive, a number projected to exceed 22.1 million by 2030. The most prevalent cancers in 2019 were prostate, colon and rectum, and melanoma among males, and breast, uterine corpus, and colon and rectum among females. More than half of survivors were diagnosed within the past decade, and nearly two-thirds are aged 65 or older. The report details treatment patterns, survival rates, and short-term and long-term health effects for various cancers, including breast, colorectal, leukemia, lymphoma, lung, melanoma, prostate, testicular, and thyroid cancers. It emphasizes the unique medical and psychosocial needs of cancer survivors and the importance of proactive assessment and management by follow-up care providers. The report also discusses the need for evidence-based resources to optimize care for this growing population.